Found 10 matching trials
Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence
PHASE3Phase III, randomized, double-blind, double-dummy, active-controlled, paral...
Location
Parkway Medical Center
Monthly Versus Daily Buprenorphine Formulations for Treatment of Opiate Use Disorder
PHASE4Opioid use disorder and opioid-related deaths are increasing across Canada....
Location
Royal Victoria Regional Health Centre
Recombinant Human Endostatin (EndostarTM) Injection in Treatment of Recurrent Metastatic Breast Cancer
PHASE2Endostatin has been widely applied for the clinical treatment of partial pr...
Location
Third Affiliated Hospital of Xinjiang Medical University
NX in Luminal B Breast Cancer Patients After Neoadjuvant Chemotherapy
PHASE3This is a prospective, randomized, open-lable phase III clinical trial eval...
Location
Cancer Hospital/ Institute, Fudan University
Non-invasive Monitoring: Impact on Patient Management and Outcomes
N/AEnhancing patient monitoring in SNFs and ALFs is crucial due to challenges ...
Location
Oak Village Healthcare
Post-Operative Evaluation of Endodontic Microsurgeries Done Using a Piezoelectric Ultrasonic Technique: An in Vivo Study
NAThe aim of the study was to evaluate the effect of Piezosurgery and Trephin...
Location
Al-Azhar university
Mutation Scores and Differential Protein Evaluating Efficacy in Adjuvant Chemotherapy in HER2(-) Luminal B Breast Cancer
PHASE3We plan to carry out a prospective, randomized, open phase III clinical tri...
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients With Advanced Solid Tumors
PHASE1This is an open-label phase 1 study with expansion. The study will start wi...
Status
Active Not Recruiting
Location
UC San Diego Moores Cancer Center
Effects of Pentazocine Versus Lorazepam on Manic Symptoms
PHASE2Pilot data indicates that pentazocine decreases manic symptoms in hospitali...
Starting Treatment With Agonist Replacement Therapies (START)
PHASE4The Food and Drug Administration (FDA) has requested a study comparing bupr...